Vimarsana
Biggest News Aggregation in the World

Page 25 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

Albireo Appoints New Members to Board of Directors - Vimarsana News

Albireo Appoints New Members to Board of Directors

– Habib Dable, Former President and CEO of Acceleron Pharma, and Susan Alesina, Vice President, National Business Development and Alliances at Boston...

US Merger Control in the Pharmaceutical Sector - Vimarsana News

US Merger Control in the Pharmaceutical Sector

In the United States, mergers and acquisitions are reviewed by the Department of Justice (DOJ) or the Federal Trade Commission (FTC). These agencies…

Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight - Vimarsana News

Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight

DelveInsight’s pulmonary hypertension pipeline report depicts a robust space with 80+ active players working to develop...

Blueprint Medicines Reports Second Quarter 2022 Results - Vimarsana News

Blueprint Medicines Reports Second Quarter 2022 Results

-- Achieved $36.5 million in total revenues, including $28.5 million in AYVAKIT® (avapritinib) net product revenues representing 20 percent AYVAKIT revenue...

Merck Is in Advanced Talks to Acquire Biotech Firm Seagen - Vimarsana News

Merck Is in Advanced Talks to Acquire Biotech Firm Seagen

Seagen develops cancer therapies using antibody conjugate and sugar-engineered antibody technologies.